Search
for
Sort by
Research 271–300 of 1000+
- Lifestyle Diseases and the Hair Growth Cycle: A multidisciplinary approach using Nourkrin® with Marilex®, a proteoglycan replacement therapy, for anagen induction and maintenance
- Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia)
- Polycystic ovarian syndrome
- Alopecias
- Immunotherapies
- Main Plenary Sessions: Summaries of Papers
- Dermatologic therapy: December 1987 to December 1988
- Psychological burden of alopecia areata in patients with cancer: A narrative review
- Chemotherapy-induced alopecia
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- TRICHOPATHOPHOBIA.
- A case of widespread non-pigmented hair regrowth in diffuse alopecia areata
- Alopecia areata
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- The Role of Micronutrients in Alopecia Areata: A Review
- Anagen effluvium
- Effects of anticonvulsant drugs on chromosomes.
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Management of Clinical Side Effects of DMPA
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- An unusual side effect of azathioprine
- CONTRACEPTION AND THE SKIN
- Alopecia Areata and Alopecia Areata Incognita
- Hair follicle culture—a historical perspective
- Alopecia Associated with Sulfasalazine
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Reversible Anagen Effluvium Induced by Azathioprine: A Rare Adverse Effect Case Report